InnovAge Holding Corp. Operating Cash Flow
InnovAge Holding Corp. (INNV) reported Operating Cash Flow of $64.71 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-09
- InnovAge Holding Corp. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $21.29M, a 136.52% increase year-over-year.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $18.14M, a 26.34% decline year-over-year.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $21.36M, a 216.32% increase year-over-year.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $3.92M.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for fiscal 2026 was $64.71M, a 96.90% increase from fiscal 2025.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for fiscal 2025 was $32.87M.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for fiscal 2024 was -$36.90M, a 282.34% decline from fiscal 2023.
- InnovAge Holding Corp. net cash provided by (used in) operating activities for fiscal 2023 was $20.24M, a 25.88% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $39.43M derived: sum of 2 quarters · filed 2026-09-09 | $60.79M derived: sum of 3 quarters · filed 2026-09-09 | $64.71M 10-K · filed 2026-09-09 |
| 2026-03-31 | $18.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $39.50M derived: sum of 2 quarters · filed 2026-05-08 | $43.42M 10-Q · filed 2026-05-08 | $52.43M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $21.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $25.29M 10-Q · filed 2026-02-03 | $34.29M derived: sum of 3 quarters · filed 2026-09-09 | $58.91M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $3.92M 10-Q · filed 2025-11-04 | $12.93M derived: sum of 2 quarters · filed 2026-09-09 | $37.55M derived: sum of 3 quarters · filed 2026-09-09 | $44.31M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $33.63M derived: sum of 2 quarters · filed 2026-09-09 | $40.38M derived: sum of 3 quarters · filed 2026-09-09 | $32.87M 10-K · filed 2026-09-09 |
| 2025-03-31 | $24.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $31.38M derived: sum of 2 quarters · filed 2026-05-08 | $23.86M 10-Q · filed 2026-05-08 | $25.74M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $6.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$763.00K 10-Q · filed 2026-02-03 | $1.11M derived: sum of 3 quarters · filed 2026-02-03 | $4.62M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$7.52M 10-Q · filed 2025-11-04 | -$5.64M derived: sum of 2 quarters · filed 2025-11-04 | -$2.13M derived: sum of 3 quarters · filed 2025-11-04 | -$11.43M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $5.38M derived: sum of 2 quarters · filed 2025-09-09 | -$3.91M derived: sum of 3 quarters · filed 2025-09-09 | -$36.90M 10-K · filed 2025-09-09 |
| 2024-03-31 | $3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$5.79M derived: sum of 2 quarters · filed 2025-05-06 | -$38.77M 10-Q · filed 2025-05-06 | -$25.62M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$9.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | -$42.28M 10-Q · filed 2025-02-04 | -$29.13M derived: sum of 3 quarters · filed 2025-02-04 | -$53.00K derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$32.98M 10-Q · filed 2024-11-05 | -$19.83M derived: sum of 2 quarters · filed 2024-11-05 | $9.24M derived: sum of 3 quarters · filed 2024-11-05 | -$25.88M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $42.23M derived: sum of 2 quarters · filed 2024-09-10 | $7.11M derived: sum of 3 quarters · filed 2024-09-10 | $20.24M 10-K · filed 2024-09-10 |
| 2023-03-31 | $29.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$6.04M derived: sum of 2 quarters · filed 2024-05-07 | $7.08M 10-Q · filed 2024-05-07 | $10.33M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$35.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | -$21.99M 10-Q · filed 2024-02-06 | -$18.75M derived: sum of 3 quarters · filed 2024-02-06 | -$26.27M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $13.13M 10-Q · filed 2023-11-07 | $16.37M derived: sum of 2 quarters · filed 2023-11-07 | $8.85M derived: sum of 3 quarters · filed 2023-11-07 | $19.87M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$4.28M derived: sum of 2 quarters · filed 2023-09-12 | $6.74M derived: sum of 3 quarters · filed 2023-09-12 | $27.30M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$7.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $3.50M derived: sum of 2 quarters · filed 2023-05-09 | $24.06M 10-Q · filed 2023-05-09 | $33.54M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $11.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $31.58M 10-Q · filed 2023-02-07 | $41.06M derived: sum of 3 quarters · filed 2023-02-07 | $24.77M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $20.56M 10-Q · filed 2022-11-08 | $30.04M derived: sum of 2 quarters · filed 2022-11-08 | $13.75M derived: sum of 3 quarters · filed 2022-11-08 | $31.07M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $9.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$6.80M derived: sum of 2 quarters · filed 2022-09-13 | $10.51M derived: sum of 3 quarters · filed 2022-09-13 | -$7.55M 10-K · filed 2022-09-13 |
| 2021-03-31 | -$16.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $1.03M derived: sum of 2 quarters · filed 2022-05-10 | -$17.03M 10-Q · filed 2022-05-10 | $6.78M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $17.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$743.00K 10-Q · filed 2022-02-09 | $23.06M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$18.06M 10-Q · filed 2021-11-09 | $5.75M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $23.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $43.83M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $20.02M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |